Gabriella Miller Kids First Research Act 2.0
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Gabriella Miller Kids First Research Act 2.0
This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6556: Gabriella Miller Kids First Research Act 2.0. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6556/
"H.R. 6556: Gabriella Miller Kids First Research Act 2.0." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6556/.
H.R. 6556, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6556/.
[H.R. 6556: Gabriella Miller Kids First Research Act 2.0](https://openamerica.io/bill/116-HR-6556/)